Brottby, Sweden

Mikael Åmark

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Ab. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 309(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Mikael Åmark: Innovator Behind the Autoinjector Technology**

Introduction

Mikael Åmark, an accomplished inventor based in Brottby, Sweden, has made significant contributions to the medical technology field with his innovative design of an autoinjector. This device aims to enhance the ease and accuracy of injections, playing a crucial role in improving patient care.

Latest Patents

Mikael Åmark holds a patent for his innovative autoinjector. The device is designed for replaceable containers of syringe type and features a robust construction that includes a housing, a container carrier, and sophisticated mechanisms for autopenetration and autoinjection. The autoinjector's control system is designed to sequence the operation of these mechanisms, ensuring safety and ease of use during injections.

Career Highlights

Mikael is currently associated with Pharmacia AB, a company known for its commitment to developing advanced pharmaceutical technologies. His role there has allowed him to pioneer cutting-edge inventions that streamline medical procedures and improve patient outcomes.

Collaborations

Throughout his career, Mikael Åmark has collaborated with industry professionals such as Thomas Bergens. Their combined expertise has driven the successful development of medical devices that are set to transform the landscape of healthcare.

Conclusion

Mikael Åmark exemplifies the spirit of innovation in the medical field. His work on the autoinjector reflects a dedication to improving healthcare delivery through technology. With continued support from his team and company, he is likely to contribute even more groundbreaking inventions in the years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…